- Home
- TRVI vs HIPO Comparison
TRVI vs HIPO Comparison
Compare TRVI & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- HIPO
- Stock Information
- Founded
- TRVI 2011
- HIPO 2015
- Country
- TRVI United States
- HIPO United States
- Employees
- TRVI N/A
- HIPO N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- HIPO Property-Casualty Insurers
- Sector
- TRVI Health Care
- HIPO Finance
- Exchange
- TRVI Nasdaq
- HIPO Nasdaq
- Market Cap
- TRVI 725.7M
- HIPO 694.3M
- IPO Year
- TRVI 2019
- HIPO N/A
- Fundamental
- Price
- TRVI $6.89
- HIPO $26.34
- Analyst Decision
- TRVI Strong Buy
- HIPO Strong Buy
- Analyst Count
- TRVI 9
- HIPO 4
- Target Price
- TRVI $19.94
- HIPO $31.50
- AVG Volume (30 Days)
- TRVI 1.6M
- HIPO 293.0K
- Earning Date
- TRVI 08-07-2025
- HIPO 08-06-2025
- Dividend Yield
- TRVI N/A
- HIPO N/A
- EPS Growth
- TRVI N/A
- HIPO N/A
- EPS
- TRVI N/A
- HIPO N/A
- Revenue
- TRVI N/A
- HIPO $397,300,000.00
- Revenue This Year
- TRVI N/A
- HIPO $29.23
- Revenue Next Year
- TRVI N/A
- HIPO $21.57
- P/E Ratio
- TRVI N/A
- HIPO N/A
- Revenue Growth
- TRVI N/A
- HIPO 55.80
- 52 Week Low
- TRVI $2.36
- HIPO $14.58
- 52 Week High
- TRVI $7.48
- HIPO $35.44
- Technical
- Relative Strength Index (RSI)
- TRVI 64.54
- HIPO 44.94
- Support Level
- TRVI $5.41
- HIPO $25.89
- Resistance Level
- TRVI $6.08
- HIPO $29.84
- Average True Range (ATR)
- TRVI 0.32
- HIPO 1.15
- MACD
- TRVI 0.14
- HIPO -0.38
- Stochastic Oscillator
- TRVI 89.91
- HIPO 7.35
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About HIPO Hippo Holdings Inc.
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.